For example, although targeting tumor metabolism of glutamine by GLS inhibition could theoretically block the herein studied mechanism of metabolic reprogramming, the clinically applicable GLS inhibitor CB-839 has very low BBB permeability59. Here, GLS is linked to neoplasm.